Reports Hub
Latest Reports > 2022
West Midlands Ambulance Service University NHS Foundation Trust 2021/22
Healthwatch Birmingham and Healthwatch Solihull statement on West Midlands Ambulance Service University NHS Foundation Trust’s Quality Account for 2021/22.
Mental health and wellbeing plan
Healthwatch Birmingham’s response to the Department of Health and Social Care’s (DHSC) call for evidence for its Mental health and wellbeing plan.
10 year cancer plan
Healthwatch Birmingham’s response to the call for evidence for the Department of Health and Social Care 10 year cancer plan for England.
UK Covid-19 Inquiry Terms of Reference
Healthwatch Birmingham’s response to the consultation on the Terms of Reference for the UK Covid-19 Inquiry.
Operational guidance to implement a lifetime cap on care costs
Healthwatch Birmingham’s response to the Department of Health and Social Care consultation on guidance to implement a lifetime cap on care costs.
Clinical review of standards for cancer
Healthwatch Birmingham’s response to the NHS England and NHS Improvement
consultation on clinical review of standards for cancer, to increase rates of earlier diagnosis.
Evidence-Based Interventions – List 3 clinical guidance proposals
Healthwatch Birmingham’s response to the consultation on the Evidence-based Intervention Programme guidance on when it is and is not appropriate to carry out specific interventions.
Provider selection regime
Healthwatch Birmingham’s response to the Department of Health and Social Care consultation on proposals for the provider selection regime.
Impact Report: Improvements to visual impairment rehabilitation services provided by Birmingham City Council
This report details the actions taken to improve Birmingham City Council’s support for people with sight loss and visual impairment, following our earlier investigation into visual impairment rehabilitation services.
Making Gina 10 microgram vaginal tablets (Estradiol) available from pharmacies
Healthwatch Birmingham’s response to the Medicines and Healthcare products Regulatory Agency’s (MHRA) consultation on the proposal to make Gina 10 microgram vaginal tablets (Estradiol) available from pharmacies.
Categories
- 2017 3
- 2016 2
- 2022 32
- 2023 16
- 2024 25
- Investigations 27
- Impact Reports 16
- Annual Reports 7
- Consultations 70
- 2020 17
- 2019 11
- Quality Accounts 27
- 2018 11
- 2021 19